Medtech Conference Co-Commander Hykes Reviews the Troops
We’re less than one week away from the 16th annual Medtech Conference.
To preview the day, Kevin Hykes, CEO of Metavention and operating partner of Versant Ventures, joins us on the Medtech Talk podcast to review a few highlights of the agenda, including his keynote interview with Michael Mahoney, chairman and CEO of Boston Scientific Corp.
Co-Chair Stacy Enxing Seng, venture partner at Lightstone Ventures, will interview Joe Almeida, CEO and chairman of Baxter International later in the afternoon.
Here’s the good news. If you’re unable to make the conference, we’ll broadcast the two keynote conversations on Facebook LIVE along with the afternoon award ceremony featuring Mark Foley, the former CEO and president of Zeltiq Aesthetics, acquired in April by Allergan for $2.4 billion.
To watch, like the
Healthegy Facebook page. On Thursday, log onto Facebook, go to the Healthegy page and view the broadcast live. If you’re watching on your phone you’ll need to download the Facebook app.
You can find the times for each presentation on the Medtech Conference page.
Hykes will wrap up his two-year term as co-chair of the conference to be held this Thursday. In this
Medtech Talk podcast, Hykes reflects on his leadership of the program he assembled with Enxing Seng, who is completing her first year as co-chair.
Kevin Hykes
President & CEO
Relievant Medsystems
Kevin Hykes is the CEO and President of Relievant Medsystems, a privately held medical device company that has developed the Intracept® procedure, a breakthrough treatment for chronic lower back pain. Prior to Relievant, Kevin was an Operating Partner at Versant Ventures and Chairman and CEO of Metavention, Inc., a privately held medical device company focused on the development of interventional therapies for the treatment of type 2 diabetes. Kevin remains Chairman of the Board of Directors at Metavention. Prior to Metavention, Kevin was President and CEO of Cameron Health, developer of the subcutaneous implantable defibrillator, until its acquisition by Boston Scientific in 2012. Prior to Cameron Health, he was the Chief Commercial Officer of Visiogen, Inc., a privately held ophthalmology company which was acquired by Abbott Medical Optics in 2009. Previously, Kevin spent over sixteen years at Medtronic, where he held leadership positions in the CRM, Neurostimulation and Cardiac Surgery businesses in the US and Europe.
Kevin received his MBA from Northwestern University and a BBA from the University of Wisconsin. In addition to his role as Chairman of Metavention, Kevin serves as an independent board member at Veran Medical Technologies and the Courage Kenny Rehabilitation Institute Foundation.
